Safety Shot Inc (SHOT)
USD 0.48
(5.52%)
USD 0.48
(5.52%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 12.7 Million USD | 46.24% |
| 2022 | 8.69 Million USD | -53.94% |
| 2021 | 18.86 Million USD | 189.13% |
| 2020 | 6.52 Million USD | 774.99% |
| 2019 | 745.78 Thousand USD | 289.82% |
| 2018 | 191.31 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 9.21 Million USD | -27.49% |
| 2024 Q2 | 10.69 Million USD | 16.06% |
| 2023 Q3 | 11.33 Million USD | 2.27% |
| 2023 Q1 | 10.9 Million USD | 25.5% |
| 2023 Q2 | 11.07 Million USD | 1.59% |
| 2023 FY | 12.7 Million USD | 46.24% |
| 2023 Q4 | 12.7 Million USD | 12.16% |
| 2022 Q1 | 13.29 Million USD | -29.53% |
| 2022 FY | 8.69 Million USD | -53.94% |
| 2022 Q4 | 8.69 Million USD | -28.09% |
| 2022 Q3 | 12.08 Million USD | -15.99% |
| 2022 Q2 | 14.38 Million USD | 8.2% |
| 2021 Q2 | 6.32 Million USD | 24.45% |
| 2021 Q3 | 31.44 Million USD | 397.25% |
| 2021 Q4 | 18.86 Million USD | -40.01% |
| 2021 FY | 18.86 Million USD | 189.13% |
| 2021 Q1 | 5.08 Million USD | -22.12% |
| 2020 Q4 | 6.52 Million USD | 269.52% |
| 2020 Q2 | 1.96 Million USD | -3.52% |
| 2020 Q1 | 2.03 Million USD | 172.84% |
| 2020 FY | 6.52 Million USD | 774.99% |
| 2020 Q3 | 1.76 Million USD | -10.05% |
| 2019 FY | 745.78 Thousand USD | 289.82% |
| 2019 Q4 | 745.78 Thousand USD | 0.0% |
| 2019 Q2 | 135.7 Thousand USD | -19.85% |
| 2019 Q1 | 169.31 Thousand USD | 0.0% |
| 2018 FY | 191.31 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | 98.888% |
| Embecta Corp. | 1.21 Billion USD | 98.953% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | 98.595% |
| Dynavax Technologies Corporation | 997.09 Million USD | 98.725% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | 93.824% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | 99.193% |
| PainReform Ltd. | 9.93 Million USD | -27.988% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | 77.866% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | 53.526% |
| SCYNEXIS, Inc. | 128.41 Million USD | 90.103% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | 45.046% |
| Cosmos Health Inc. | 66.29 Million USD | 80.83% |
| Journey Medical Corporation | 76.84 Million USD | 83.462% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | 53.526% |
| Alpha Teknova, Inc. | 128.58 Million USD | 90.116% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | 98.255% |
| Bright Green Corporation | 17.4 Million USD | 26.972% |
| Procaps Group, S.A. | 460.18 Million USD | 97.238% |
| Theratechnologies Inc. | 77.76 Million USD | 83.658% |
| Harrow Health, Inc. | 311.75 Million USD | 95.923% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | 14.663% |
| Biofrontera Inc. | 27.93 Million USD | 54.5% |
| DURECT Corporation | 45.18 Million USD | 71.876% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | 99.098% |
| Cronos Group Inc. | 1.13 Billion USD | 98.88% |
| OptiNose, Inc. | 107.72 Million USD | 88.203% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | 97.302% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | 77.284% |
| RedHill Biopharma Ltd. | 23.04 Million USD | 44.856% |
| Organogenesis Holdings Inc. | 460.02 Million USD | 97.237% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | -6.637% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | 84.459% |
| Radius Health, Inc. | 1.71 Billion USD | 99.259% |
| Universe Pharmaceuticals INC | 53.28 Million USD | 76.15% |
| ProPhase Labs, Inc. | 91.92 Million USD | 86.175% |
| Phibro Animal Health Corporation | 982.18 Million USD | 98.706% |
| Procaps Group S.A. | 460.18 Million USD | 97.238% |
| Alvotech | 950.09 Million USD | 98.662% |
| TherapeuticsMD, Inc. | 43.3 Million USD | 70.655% |
| Viatris Inc. | 47.68 Billion USD | 99.973% |
| Rockwell Medical, Inc. | 52.17 Million USD | 75.64% |
| Aytu BioPharma, Inc. | 118.09 Million USD | 89.238% |
| SIGA Technologies, Inc. | 254.83 Million USD | 95.013% |
| Tilray Brands, Inc. | 4.33 Billion USD | 99.707% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | 95.357% |
| Shineco, Inc. | 84.17 Million USD | 84.902% |
| PetIQ, Inc. | 868.22 Million USD | 98.536% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -50.615% |
| Incannex Healthcare Limited | 17.04 Million USD | 25.446% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 99.609% |
| Alimera Sciences, Inc. | 153.52 Million USD | 91.722% |
| Silver Spike Investment Corp. | 88.57 Million USD | 85.652% |
| Assertio Holdings, Inc. | 286.41 Million USD | 95.563% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -113.537% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | 62.394% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | 59.322% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | 4.064% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | 95.133% |
| Hempacco Co., Inc. | 18.04 Million USD | 29.562% |
| Talphera, Inc. | 20.39 Million USD | 37.685% |
| Alvotech | 950.09 Million USD | 98.662% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | 96.871% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | 99.23% |
| Currenc Group, Inc. | 141.49 Million USD | 91.018% |
| Kamada Ltd. | 351.96 Million USD | 96.389% |
| Indivior PLC | 1.95 Billion USD | 99.349% |
| Evoke Pharma, Inc. | 7.06 Million USD | -79.799% |
| Flora Growth Corp. | 23.62 Million USD | 46.207% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | 4.064% |
| Evolus, Inc. | 188.99 Million USD | 93.275% |
| HUTCHMED (China) Limited | 1.27 Billion USD | 99.007% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | 99.16% |
| Akanda Corp. | 8.83 Million USD | -43.769% |